Fadaltran (BAY 1193397) is an orally active α2C-adrenoreceptor antagonist. Fadaltran can be used for the study of diabetic foot ulcers.
Products | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Adrenergic Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.